Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals

Biological Chemistry

Volumn 389, Issue 5, 2008, Pages 551-559

  Schalich, Juliane ^a   Vytvytska, Oresta ^a   Zauner, Wolfgang ^a   Fischer, Michael B ^b   Buschle, Michael ^a   Aichinger, Gerald ^a   Klade, Christoph S ^a  

^a INTERCELL AG   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

ELIspot assay; HLA; Immunotherapy; Overlapping peptides; T cell epitope

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; EPITOPE; HLA A2 ANTIGEN; HLA B12 ANTIGEN; HLA B35 ANTIGEN; HLA B44 ANTIGEN; HLA B7 ANTIGEN;

ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; IMMUNOTHERAPY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; SEROLOGY; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS VACCINES; DRUG EVALUATION, PRECLINICAL; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; MOLECULAR SEQUENCE DATA; MONOCYTES; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; T-LYMPHOCYTES; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 5;

EID: 45749146192     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.065     Document Type: Article

References (38)

1. + memory T cell response to cytomegalovirus. J. Immunol. 167, 1151-1163.
2. Diamond, D.J., York, J., Sun, J.Y., Wright, C.L., and Forman, S. (1997). Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 90, 1751-1767.
3. Drew, W.L. and Lalezari, J.P. (1999). Cytomegalovirus: disease syndromes and treatment. Curr. Clin. Top. Infect. Dis. 19, 16-29.
4. +-T-cell response to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J. Virol. 77, 5226-5240.
5. Fowler, K.B., Stagno, S., Pass, R.F., Britt, W.J., Boll, T.J., and Alford, C.A. (1992). The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. 326, 663-667.
6. Hebart, H., Rudolph, T., Loeffler, J., Middeldorp, J., Ljubicic, T., Jahn, G., and Einsele, H. (2002). Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation. Bone Marrow Transplant. 30, 181-187.
7. - T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens. J. Immunol. Methods 191, 131-142.
8. + T lymphocytes producing tumor necrosis factor a spots in response to peptide antigens. J. Immunol. Methods 203, 141-152.
9. +-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J. Virol. 73, 8179-8184.
10. Kern, F., Faulhaber, N., Frommel, C., Khatamzas, E., Prosch, S., Schonemann, C., Kretzschmar, I., Volkmer-Engert, R., Volk, H.D., and Reinke, P. (2000). Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur. J. Immunol. 30, 1676-1682.
11. Kern, F., Bunde, T., Faulhaber, N., Kiecker, F., Khatamzas, E., Rudawski, I.M., Pruss, A., Gratama, J.W., Volkner-Engert, R., Ewert, R., et al. (2002). Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J. Infect. Dis. 185, 1709-1716.
12. Khattab, B.A., Lindenmaier, W., Frank, R., and Link, H. (1997). Three T-cell epitopes within the C-terminal 265 amino acids of the matrix protein pp65 of human cytomegalovirus recognized by human lymphocytes. J. Med. Virol. 52, 68-76.
13. Kleihauer, A., Grigoleit, U., Hebart, H., Moris, A., Brossart, P., Muhm, A., Stevanovic, S., Rammensee, H.G., Sinzger, C., Riegler, S., et al. (2001). Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells. Br. J. Haematol. 113, 231-239.
14. Kondo, E., Akatsuka, Y., Kuzushima, K., Tsujimura, K., Asakura, S., Tajima, K., Kagami, Y., Kodera, Y., Tanimoto, M., Morishima, Y., and Takahashi, T. (2004). Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles. Blood 103, 630-638.
15. + T-lymphocyte immune response to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA B*07 alleles. Hum. Immunol. 64, 440-452.
16. + memory T cells. J. Exp. Med. 186, 859-865.
17. +-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J. Virol. 76, 6104-6113.
18. Maecker, H.T., Dunn, H.S., Suni, M.A., Khatamzas, E., Pitcher, C.J., Bunde, T., Persaud, N., Trigona, W., Fu, T.M., Sinclair, E., et al. (2001). Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J. Immunol. Methods 255, 27-40.
19. + virus-specific cytotoxic T lymphocytes. J. Med. Virol. 43, 103-110.
20. Nijman, H.W., Houbiers, J.G., Vierboom, M.P., van der Burg, S.H., Drijfhout, J.W., D'Amaro, J., Kenemans, P., Melief, C.J., and Kast, W.M. (1993). Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur. J. Immunol. 23, 1215-1219.
21. Pass, R.F. (2001). Cytomegalovirus. In: Fields Virology, 4th edition, D.M. Knipe and P.M. Howley, eds. (Philadelphia, USA: Lippincott-Ravens Publishers).
22. Ploegh, H.L. (1998). Viral strategies of immune evasion. Science 280, 248-253.
23. Plotkin, S.A. (1999). Vaccination against cytomegalovirus, the changeling demon. Pediatr. Infect. Dis. J. 18, 313-325.
24. Rammensee, H., Bachmann, J., Emmerich, N.P., Bachor, O.A., and Stevanovic, S. (1999). SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50, 213-219.
25. Reddehase, M.J. (2000). The immunogenicity of human and murine cytomegaloviruses. Curr. Opin. Immunol. 12, 390-396.
26. Retiere, C., Prod'homme, V., Imbert-Marcille, B.M., Bonneville, M., Vie, H., and Hallet, M.M. (2000). Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response. J. Virol. 74, 3948-3952.
27. Saulquin, X., Ibisch, C., Peyrat, M.A., Scotet, E., Hourmant, M., Vie, H., Bonneville, M., and Houssaint, E. (2000). A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening. Eur. J. Immunol. 30, 2531-2539.
28. Schmittel, A., Keilholz, U., Bauer, S., Kuhne, U., Stevanovic, S., Thiel, E., and Scheibenbogen, C. (2001). Application of the IFN-γ ELISPOT assay to quantify T cell responses against proteins. J. Immunol. Methods 247, 17-24.
29. Sette, A. and Sidney, J. (1999). Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50, 201-212.
30. Solache, A., Morgan, C.L., Dodi, A.I., Morte, C., Scott, I., Baboonian, C., Zal, B., Goldman, J., Grundy, J.E., and Madrigal, J.A. (1999). Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. J. Immunol. 163, 5512-5518.
31. Steven, N.M., Annels, N.E., Kumar, A., Leese, A.M., Kurilla, M.G., and Rickinson, A.B. (1997). Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J. Exp. Med. 185, 1605-1618.
32. st century (Washington, DC, USA: National Academy Press).
33. Tobery, T.W., Wang, S., Wang, X.M., Neeper, M.P., Jansen, K.U., McClements, W.L., and Caulfield, M.J. (2001). A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay. J. Immunol. Methods 254, 59-66.
34. + T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc. Natl. Acad. Sci. USA 88, 11276-11280.
35. Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D., and Riddell, S.R. (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038-1044.
36. Weekes, M.P., Wills, M.R., Mynard, K., Carmichael, A.J., and Sissons, J.G. (1999). The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J. Virol. 73, 2099-2108.
37. Wills, M.R., Carmichael, A.J., Mynard, K., Jin, X., Weekes, M.P., Plachter, B., and Sissons, J.G. (1996). The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70, 7569-7579.
38. Zaia, J.A., Sissons, J.G., Riddell, S., Diamond, D.J., Wills, M.R., Carmichael, A.J., Weekes, M.P., Gandhi, M., Rosa, C.L., Villacres, M., et al. (2000). Status of cytomegalovirus prevention and treatment in 2000. Hematology 2000, 339-355.